The Dr A.H. Heineken Prize for (Bio)medical and Clinical Sciences honours pioneering work and research excellence in medicine, biomedical and clinical research, and related life sciences in their medical context. Biochemistry and biophysics fall within this domain where the research is primarily biomedical or medically oriented.
Every two years, the prize is awarded to a renowned researcher who has made groundbreaking discoveries in the field. The prize consists of an unrestricted cash award of EUR 300,000 and a trophy, funded by the Alfred Heineken Fondsen Foundation.
History of the prize
Alfred Heineken established the Dr A.H. Heineken Prize for Medicine in 1989. At the time, he felt that medical researchers were not given the recognition they deserved.
In 2026, the Alfred Heineken Fondsen Foundation renamed the prize the Dr A.H. Heineken Prize for (Bio)medical and Clinical Sciences, broadening its scope to explicitly encompass both biomedical and clinical research.
Notable laureates
Laureates of the prize include some of the world’s leading scientists. Several went on to receive the Nobel Prize. Among them are Paul Lauterbur, who revolutionised medical research and practice with the invention of magnetic resonance imaging (MRI); Elizabeth Blackburn, who discovered how telomeres protect chromosomes and identified the enzyme that produces their DNA; and Eric Kandel, who bridged the gap between the physiology of behaviour and classical psychology through his pioneering research on the molecular mechanisms underlying learning processes and memory.